Copyright
©The Author(s) 2018.
World J Gastroenterol. Sep 21, 2018; 24(35): 3965-3973
Published online Sep 21, 2018. doi: 10.3748/wjg.v24.i35.3965
Published online Sep 21, 2018. doi: 10.3748/wjg.v24.i35.3965
Technique | Focal EMR with ablation | SRER | ESD |
Efficacy in ESCC | Curative resection rate 58.6%[34] | Curative resection rate 92.3%[36] | Curative resection rate 99% to 100%[46] |
Efficacy in EAC | Eradication of neoplasia 93.4% and eradication of metaplasia 73.1%[75] | Eradication of neoplasia 94.9% and eradication of metaplasia 79.6%[75] | 95% to 97% curative resection rate[44,45] |
Recurrence | 11% for ESCC[34], 1.4% for EAC[75] | 0.7% for EAC[75] 6.9 % at one year for ESCC[36] | 0.9% to 9.8% for ESCC[58], 0.17% for EAC[56] |
Adverse events | Stricture (5% to 14%)[25,61,62], bleeding (1.1%)[75] and perforation (0.2%)[75] | Strictures (33% to 88%)[24,37], bleeding (2.4% to 25%)[24] and perforation (1.3%)[75] | Stricture (15% to 60%)[52], bleeding (0.9% to 6.7%)[52,53] and perforations (3%)[55] |
- Citation: Malik S, Sharma G, Sanaka MR, Thota PN. Role of endoscopic therapy in early esophageal cancer. World J Gastroenterol 2018; 24(35): 3965-3973
- URL: https://www.wjgnet.com/1007-9327/full/v24/i35/3965.htm
- DOI: https://dx.doi.org/10.3748/wjg.v24.i35.3965